Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,668,141 papers from all fields of science
Search
Sign In
Create Free Account
Xeloda
Known as:
Xeloda®
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
capecitabine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An open-label, randomized, controlled clinical trial to explore the curative effects between the treatment of capecitabine and andrographolide and the single capecitabine in the patients with…
Y. Shu
,
Jing Sun
,
Peifen Cai
,
Weicheng Wang
,
Xiao Han
,
Yanhong Gu
2017
Corpus ID: 78951863
TPS819Background: Colorectal cancer (CRC) is one of the most commonly diagnosed solid tumors worldwide. Current therapies for the…
Expand
2016
2016
Results of third-generation epirubicin/cisplatin/xeloda adjuvant chemotherapy in patients with radically resected gastric cancer.
C. Căinap
,
V. Nagy
,
+6 authors
S. Căinap
Journal of B.U.ON. : official journal of the…
2016
Corpus ID: 29869354
PURPOSE The purpose of this study was to evaluate the efficacy and toxicity of a third-generation chemotherapy regimen in the…
Expand
2015
2015
Clinical observation on recombinant human endostatin combined with chemotherapy for advanced gastrointestinal cancer.
Shao-rong Gao
,
Lu-Ming Li
,
Haifeng Xia
,
Guang-Ming Wang
,
Hong-yan Xu
,
Aihua Wang
Asian Pacific Journal of Cancer Prevention
2015
Corpus ID: 6425145
OBJECTIVE To explore the clinical efficacy and toxic and side effects of recombinant human endostatin (rh- endostatin/endostar…
Expand
Review
2014
Review
2014
Influence of payer source on treatment and outcomes in colorectal cancer patients in a university hospital in Thailand.
Nattapoom Sermsri
,
T. Boonpipattanapong
,
Paradee Prechawittayakul
,
S. Sangkhathat
Asian Pacific Journal of Cancer Prevention
2014
Corpus ID: 12883212
The study aimed to compare the 2 main types of insurance used by colorectal cancer (CRC) patients in a university hospital in…
Expand
Review
2013
Review
2013
t(2;11)(q31;p15) in therapy related myeloid neoplasm: case report and review of literature
A. Bhalla
,
A. Mohamed
2013
Corpus ID: 57651848
Case report of a translocation : t(2;11)(q31;p15) in therapy related myeloid neoplasm: case report and review of literature.
Review
2007
Review
2007
Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda®) monotherapy
G. Fürstenberger
,
P. Schmid
,
A. Duquesne
,
M. Ammann
,
H. Senn
Cancer Chemotherapy and Pharmacology
2007
Corpus ID: 26444221
Pancreatic neuroendocrine tumors (NETs) consist of a wide group of neoplasms with diVerent biologic and clinical characteristics…
Expand
Review
2005
Review
2005
New combinations in metastatic colorectal cancer: what are our expectations?
H. Hurwitz
The Oncologist
2005
Corpus ID: 37317107
The Oncologist 2005;10:320–322 www.TheOncologist.com Correspondence: Herbert Hurwitz, M.D., Room 3802, Duke University Medical…
Expand
2003
2003
[Experience with xeloda (capecitabine) as a component of chemotherapy for relapsing cisplatin-resistant ovarian tumors].
M. Ev
,
Gershanovich Ml
2003
Corpus ID: 76669683
The effectiveness and tolerability of xeloda (capecitabine), a tumor-reactivated oral fluoropyrimidine, alone were investigated…
Expand
2003
2003
[Combined preoperative xeloda and radiotherapy for lower rectal cancer].
Chao-ping Zhuang
,
Ting-han Li
,
Jun-wei Wu
,
G. Cai
Zhonghua zhong liu za zhi [Chinese journal of…
2003
Corpus ID: 46301506
OBJECTIVE To evaluate the effect of combined preoperative xeloda and pelvic radiotherapy on locally advanced lower rectal cancer…
Expand
2002
2002
[Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer].
Xiaoqing Liu
,
San‐tai Song
,
+4 authors
Lifang Yang
Zhonghua zhong liu za zhi [Chinese journal of…
2002
Corpus ID: 12225978
OBJECTIVE To evaluate the response rate and adverse reactions of xeloda, an analogue of 5-fluorouracil, in the treatment of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE